Changes in the convulsive threshold in the developing rat following chronic administration of pentylenetetrazol.
The acute and chronic effects of pentylentetrazol (PTZ) on convulsive behavior in the developing rat pup were investigated. Acute treatment at 10 or 15 days of age with 50 or 80 mg/kg evoked clonic or tonic-clonic convulsions from all rats. However, daily administration of equivalent dose levels from 5 to 16 days of age was associated with a marked reduction in the incidence of these convulsions. Alternate day treatment from 5 to 16 days of age with 80 mg/kg or an ascending series of dose levels (10 mg/kg/day increments) was not accompanied by a reduction in convulsive behavior. The present results indicate that treatment of infant rats with PTZ is followed by a 24-48 h increase in convulsive threshold. This phenomenon may be associated with a developmental process since daily treatment past 15 days of age was characterized by a gradual reappearance of convulsive behavior.
D000367:Age Factors; D000818:Animals; D010433:Pentylenetetrazole / Q000008:administration & dosage; D051381:Rats; D011919:Rats, Inbred Strains; D012640:Seizures / Q000139:chemically induced*
D010433:Pentylenetetrazole